Verici Dx plc (LON:VRCI – Get Free Report) shares were down 21.3% on Monday . The company traded as low as GBX 1.26 ($0.02) and last traded at GBX 1.26 ($0.02). Approximately 176,434 shares traded hands during trading, a decline of 85% from the average daily volume of 1,157,438 shares. The stock had previously closed at GBX 1.60 ($0.02).
Verici Dx Trading Up 3.9%
The firm has a market cap of £4.33 million, a price-to-earnings ratio of -0.83 and a beta of 1.59. The business’s 50-day moving average price is GBX 2.05 and its two-hundred day moving average price is GBX 2.94. The company has a debt-to-equity ratio of 4.64, a current ratio of 4.54 and a quick ratio of 8.49.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
See Also
- Five stocks we like better than Verici Dx
- With Risk Tolerance, One Size Does Not Fit All
- Tesla: Get Ready To See It Trading Above $400 Again
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- ON Holding Surges, Leads High-End Retailers Into Reversal
- How to Invest in the Best Canadian Stocks
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
